Efficacy News and Research

RSS
BioMarin commences GALNS Phase 3 trial in patients with Morquio A Syndrome

BioMarin commences GALNS Phase 3 trial in patients with Morquio A Syndrome

FDA, Optivia collaborate to examine effect of dietary supplements in drug-induced liver injury

FDA, Optivia collaborate to examine effect of dietary supplements in drug-induced liver injury

FDA approves NCI's Sodium Fluoride F18 NDA for use in bone scans

FDA approves NCI's Sodium Fluoride F18 NDA for use in bone scans

Biogen Idec 2010 total revenues increase 8% to $4.7 billion

Biogen Idec 2010 total revenues increase 8% to $4.7 billion

Discovery Labs provides expanded update on efforts to gain FDA marketing authorization for Surfaxin in RDS

Discovery Labs provides expanded update on efforts to gain FDA marketing authorization for Surfaxin in RDS

VBL commences two studies to evaluate efficacy, safety of VB-111 in advanced cancers

VBL commences two studies to evaluate efficacy, safety of VB-111 in advanced cancers

GATTEX Phase 3 pivotal study reaches primary efficacy endpoint of reducing PN in patients with SBS

GATTEX Phase 3 pivotal study reaches primary efficacy endpoint of reducing PN in patients with SBS

Alexion announces acquisition of Taligen Therapeutics

Alexion announces acquisition of Taligen Therapeutics

Scientists to commence new DNA vaccine trial for use in patients with leukemia

Scientists to commence new DNA vaccine trial for use in patients with leukemia

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

EVP of Advaxis' Science & Operations moderates Live Cancer Vaccines panel discussion

EVP of Advaxis' Science & Operations moderates Live Cancer Vaccines panel discussion

Phase III study shows tapentadol ER relieves chronic pain associated with DPN

Phase III study shows tapentadol ER relieves chronic pain associated with DPN

WOUNDS article profiles efficacy of Quick-Med's antimicrobial BIOGUARD dressings

WOUNDS article profiles efficacy of Quick-Med's antimicrobial BIOGUARD dressings

Phase II trial finds fostamatinib ineffective in RA patients not responsive to biologic agents

Phase II trial finds fostamatinib ineffective in RA patients not responsive to biologic agents

Preclinical data on Inovio’s intradermal electroporation delivery devices presented at Phacilitate Vaccine Forum

Preclinical data on Inovio’s intradermal electroporation delivery devices presented at Phacilitate Vaccine Forum

CSL Behring receives marketing approval for HAE drug Berinert in Israel

CSL Behring receives marketing approval for HAE drug Berinert in Israel

Discovery of aldose reductase enzyme can result in new therapies for asthma and COPD

Discovery of aldose reductase enzyme can result in new therapies for asthma and COPD

Positive results from RXi's sd-rxRNA technology for development of novel therapeutics

Positive results from RXi's sd-rxRNA technology for development of novel therapeutics

Provectus announces completion of PV-10 Phase 1 trial in patients with liver cancer

Provectus announces completion of PV-10 Phase 1 trial in patients with liver cancer

FDA grants 510(k) clearance to Sonitus Medical's SoundBite Hearing System

FDA grants 510(k) clearance to Sonitus Medical's SoundBite Hearing System

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.